Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | GRB2 | P62993 | 1/20 | 0.41 |
| ▸ | FNTA | P49354 | 5/20 | 0.41 |
| ▸ | FNTB | P49356 | 5/20 | 0.41 |
| ▸ | XIAP | P98170 | 1/20 | 0.40 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 2/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | F10 | P00742 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30591055 | 0.93 | GRB2 (0.45) | LMNAGRB2FNTAFNTBF2 | |
| SCHEMBL29380402 | 0.91 | OPRM1 (0.44) | LMNAGRB2SLC6A2 | |
| SCHEMBL29592632 | 0.90 | GRB2 (0.40) | GRB2SLC6A2 | |
| SCHEMBL29590979 | 0.90 | NAA50 (0.41) | — | |
| SCHEMBL30787962 | 0.88 | GRB2 (0.45) | GRB2 | |
| SCHEMBL29630429 | 0.87 | GRB2 (0.47) | GRB2FNTAFNTBXIAPF2 | |
| SCHEMBL30075945 | 0.86 | XIAP (0.44) | LMNAGRB2FNTAFNTBXIAP | |
| SCHEMBL31171900 | 0.86 | GRB2 (0.48) | GRB2F2 | |
| SCHEMBL30185040 | 0.86 | GRB2 (0.45) | GRB2FNTAFNTBF2 | |
| SCHEMBL29591680 | 0.85 | GRB2 (0.47) | GRB2F2SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |